Sort
39,280 grants matching “leukemia”
The chromatin remodeler Mi2 in T cell development
$383,926Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2009 · AI
Regulatory Roles of Agnoprotein in Biology of JC virus
$383,925Mahmut Safak · Temple Univ Of The Commonwealth · R01 · FY2018 · NS
Arsenic-induced apoptosis in myeloma
$383,922Lawrence H Boise · University Of Miami School Of Medicine · R01 · FY2009 · CA
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
$383,865Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$383,865Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
FANCM in repair of stalled replication forks
$383,865Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Mechanisms of the spliceosome protein SF3B1 and inhibitors
$383,849Melissa S Jurica · University Of California Santa Cruz · R01 · FY2017 · GM
Biospecimens and Primagraft Development
$383,837Jennifer R Brown · Dana-Farber Cancer Inst · P01 · FY2016 · CA
Inducing NK cells to remember and fight cancer
$383,822Jeffrey S Miller · University Of Minnesota · R01 · FY2016 · HL
Integrating mass cytometric and transcriptomic profiles of solid tumors
$383,817William A Weiss · University Of California, San Francisco · R33 · FY2016 · CA
DDR2 kinase inhibition in squamous cell lung carcinomas
$383,814Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2014 · CA
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
$383,812Michael A. Farrar · University Of Minnesota · R01 · FY2019 · CA
Deciphering Pathways Driving Inflammatory Fibroblast Effector Functions in RA
$383,789Michael B Brenner · Brigham And Women'S Hospital · R01 · FY2019 · AR
Deciphering Pathways Driving Inflammatory Fibroblast Effector Functions in RA
$383,789Michael B Brenner · Brigham And Women'S Hospital · R01 · FY2020 · AR
Deciphering Pathways Driving Inflammatory Fibroblast Effector Functions in RA
$383,789Michael B Brenner · Brigham And Women'S Hospital · R01 · FY2023 · AR
A New Murine Model for MPN: Pathololgy and Therapy of NF-E2 Overexpression
$383,788Heike L Pahl · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · CA
Function of MTG16/ETO2 in acute leukemia
$383,750Scott Hiebert · Vanderbilt University · R01 · FY2010 · HL
Role of TET2 in normal hematopoiesis and pathogenesis of myeloid malignancies
$383,750Mingjiang Xu · University Of Miami School Of Medicine · R01 · FY2016 · HL
Function of MTG16/ETO2 in acute leukemia
$383,750Scott Hiebert · Vanderbilt University · R01 · FY2009 · HL
Function of MTG16/ETO2 in acute leukemia
$383,750Scott Hiebert · Vanderbilt University · R01 · FY2008 · HL
Regulatory Roles of Agnoprotein in Biology of JC virus
$383,743Mahmut Safak · Temple Univ Of The Commonwealth · R01 · FY2019 · NS
Ehrlichia T1S Effector Regulation of Host Gene Transcription
$383,726Jere W McBride · University Of Texas Med Br Galveston · R01 · FY2015 · AI
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$383,710Paul Trippier · University Of Nebraska Medical Center · R01 · FY2020 · CA
Mechanisms of leukemogenesis in Down syndrome
$383,681John D Crispino · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
$383,655Thomas Doetschman · University Of Cincinnati · R01 · FY2006 · AI